Maynard Um
-
-
-
-
-
-
-
Cogent (COGT) Reiterated at Buy by Stifel After ASCO Presentation on Bezuclastinib
-
-
-
-
-
-
-
Raymond James Reiterates Strong Buy Rating on Cogent (COGT)
-
-
-
-
-
-
-
Raymond James Reiterates Strong Buy Rating on Cogent (COGT)
-
-
-
-
-
-
-
Cogent (COGT) PT Lowered to $49 at Leerink Partners
-
-
-
-
-
-
-
Cogent (COGT) PT Raised to $60 at Raymond James, 'remains our Analyst Current Favorite'
-
-
-
-
-
-
-
Piper Sandler: 'Biotech Has a Heartbeat: 17 Stocks to Own Through YE25'
-
-
-
-
-
-
-
Increasing unusual call option volume: COGT OMI AIP TDW AMCR ULCC DOCN PTIR
-
443,834 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

